LimaCorporate Gains FDA Clearance for Prima Shoulder Platform

LimaCorporate was granted FDA 510(k) clearance to market Prima, a new shoulder platform. In a first for the company, both the glenoid baseplate and the humeral stem are fully 3D-printed. This implant system also features Lima’s patented Trabecular Titanium (TT) technology to support strong primary fixation and secondary bone ingrowth.

PRIMA comprises a 3D-printed convertible short stem and a fully 3D-printed glenoid replacement for Reverse Shoulder Arthroplasty.

Lightweight Trabecular Titanium biomaterial is characterized by a unique net geometric structure. TT components are built using the Electron Beam Melting process.

The PRIMA TT Glenoid was designed to offer a complete solution suitable for wide range of glenoid replacement cases in Reverse Shoulder Arthroplasty. The user can easily move between baseplate designs to address different pathologies, from simple primary to complex clinical cases.

Source: LimaCorporate

Save Supplier